This finding is bolstered by the observation that mice with liver-specific inactivation of CEACAM1 (L-SACC1) or with global null deletion of Ceacam1 gene (Cc1–/–) manifest hyperinsulinemia secondary to impaired insulin clearance. The gene discussed is CEACAM1; the disease is hyperinsulinism.